找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Breast Cancer Metastasis and Drug Resistance; Progress and Prospec Aamir Ahmad Book 20131st edition Springer Science+Business Media New Yor

[復(fù)制鏈接]
樓主: 日月等
31#
發(fā)表于 2025-3-26 22:11:55 | 只看該作者
32#
發(fā)表于 2025-3-27 01:26:40 | 只看該作者
Development of Notch Pathway Inhibitors for Cancer Therapy,ing developed. In this review, we describe the basics of Notch signaling, the role of Notch in normal and cancer stem cells; finally we describe opportunity and challenges in the development of Notch inhibitors as novel targeted agents for cancer patients.
33#
發(fā)表于 2025-3-27 09:16:57 | 只看該作者
Epigenetic Factors in Breast Cancer Progression,processes involved in the initiation and progression of breast carcinogenesis. This chapter describes the major epigenetic modifications involved in breast carcinogenesis and use of various epigenetic modulators in preclinical as well as in clinical trials against breast carcinogenesis.
34#
發(fā)表于 2025-3-27 12:17:09 | 只看該作者
Understanding Tamoxifen Resistance of Breast Cancer Based on Integrative Bioinformatics Approaches,The analyses reveal that the tamoxifen resistant tumors are highly proliferative and display a distinctive expression profile for genes related to inflammation and angiogenesis compared to tamoxifen sensitive tumors. The bioinformatics analysis also identifies a set of small molecules that may reverse the tamoxifen resistance in breast tumor.
35#
發(fā)表于 2025-3-27 15:14:59 | 只看該作者
Utility, Limitations and Lacunae platinum and ruthenium based drugs against breast cancer. Chemical formulae and a brief description of the manifold biological activities of some important such compounds are provided which might be of interest to inorganic chemists, medicinal chemists, biologists, and clinicians alike.
36#
發(fā)表于 2025-3-27 21:49:23 | 只看該作者
Gabriele Gaziev,Enrico Finazzi Agròancer. Furthermore, these molecular signatures could not only help to identify new therapeutic targets, but also allow physicians to design more effective and targeted therapeutic strategies for achieving better treatment outcomes of breast cancer patients.
37#
發(fā)表于 2025-3-27 23:04:03 | 只看該作者
38#
發(fā)表于 2025-3-28 04:57:03 | 只看該作者
39#
發(fā)表于 2025-3-28 08:03:01 | 只看該作者
40#
發(fā)表于 2025-3-28 10:27:49 | 只看該作者
s and some novel signaling pathways?.Excellent source for of?This volume?comprehensively?covers recent prrogress in breast cancer research. In an effort to successfully treat breast cancer, it is imperative to a) fully understand the disease with all its heterogeneity, b) understand the factors that
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-18 18:59
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
利川市| 和政县| 崇左市| 永嘉县| 金秀| 新乡县| 香格里拉县| 革吉县| 洛川县| 渝中区| 商河县| 大同市| 志丹县| 吉水县| 吴忠市| 灌阳县| 伊川县| 台东县| 大洼县| 蓝田县| 安陆市| 行唐县| 桂林市| 长丰县| 夏津县| 遂川县| 鄂伦春自治旗| 四子王旗| 九江县| 民乐县| 江永县| 永靖县| 屏东县| 连山| 迁西县| 印江| 会宁县| 浪卡子县| 如皋市| 长岭县| 青龙|